FCP
Fidelis Capital Partners Portfolio holdings
AUM
$1.1B
1-Year Return
20.71%
This Quarter Return
+11.93%
1 Year Return
+20.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$452M
AUM Growth
+$160M
(+55%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
28.5%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
336
New
65
Increased
225
Reduced
27
Closed
8
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$12.2M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$8.09M |
| 3 |
Apple
AAPL
|
$7.24M |
| 4 |
Microsoft
MSFT
|
$6.89M |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
$4.88M |
Top Sells
Sector Composition
| 1 | Technology | 23.95% |
| 2 | Consumer Discretionary | 7.91% |
| 3 | Financials | 7.63% |
| 4 | Healthcare | 7.62% |
| 5 | Communication Services | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Shell
SHEL
$208B
| $387K | 0.09% |
5,882
+1,764
| +43% | +$116K |
|
202
Cigna
CI
$80.9B
| $387K | 0.09% |
1,291
+159
| +14% | +$47.6K |
|
203
Parker-Hannifin
PH
$96.1B
| $383K | 0.08% |
832
+224
| +37% | +$103K |
|
204
Aflac
AFL
$56.6B
| $382K | 0.08% |
4,634
+530
| +13% | +$43.7K |
|
205
Deckers Outdoor
DECK
$17.5B
| $382K | 0.08% |
3,426
+426
| +14% | +$47.5K |
|
206
United Parcel Service
UPS
$71B
| $381K | 0.08% |
2,423
+272
| +13% | +$42.8K |
|
207
Agilent Technologies
A
$36.1B
| $376K | 0.08% |
2,704
+618
| +30% | +$85.9K |
|
208
Monster Beverage
MNST
$61B
| $375K | 0.08% |
6,517
+1,381
| +27% | +$79.6K |
|
209
Schwab U.S Small- Cap ETF
SCHA
$18.8B
| $371K | 0.08% |
15,714
| – | – |
|
210
Enterprise Products Partners
EPD
$68.1B
| $368K | 0.08% |
13,978
+185
| +1% | +$4.88K |
|
211
IBM
IBM
$235B
| $367K | 0.08% |
2,245
+539
| +32% | +$88.1K |
|
212
T-Mobile US
TMUS
$274B
| $365K | 0.08% |
2,278
+121
| +6% | +$19.4K |
|
213
Martin Marietta Materials
MLM
$37.5B
| $365K | 0.08% |
732
+132
| +22% | +$65.9K |
|
214
Hershey
HSY
$37.9B
| $364K | 0.08% |
1,951
+651
| +50% | +$121K |
|
215
Phillips 66
PSX
$52.7B
| $360K | 0.08% |
2,703
+243
| +10% | +$32.4K |
|
216
AstraZeneca
AZN
$250B
| $359K | 0.08% |
5,336
+939
| +21% | +$63.2K |
|
217
Amphenol
APH
$135B
| $359K | 0.08% |
+7,236
| New | +$359K |
|
218
Moody's
MCO
$90.3B
| $359K | 0.08% |
918
-5
| -0.5% | -$1.95K |
|
219
GE Aerospace
GE
$298B
| $356K | 0.08% |
3,496
+404
| +13% | +$41.2K |
|
220
CME Group
CME
$93.9B
| $353K | 0.08% |
1,675
+275
| +20% | +$57.9K |
|
221
Bristol-Myers Squibb
BMY
$94.2B
| $350K | 0.08% |
6,822
+2,491
| +58% | +$128K |
|
222
Energy Transfer Partners
ET
$58.8B
| $344K | 0.08% |
24,949
+50
| +0.2% | +$690 |
|
223
Cooper Companies
COO
$13.6B
| $343K | 0.08% |
3,628
+980
| +37% | +$92.7K |
|
224
Marriott International Class A Common Stock
MAR
$72.5B
| $341K | 0.08% |
1,510
+171
| +13% | +$38.6K |
|
225
DuPont de Nemours
DD
$32.1B
| $340K | 0.08% |
4,421
+1,638
| +59% | +$126K |
|